The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...

Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have ...

Among 26 evaluable patients with clear cell ovarian or endometrial cancer, the objective response rate with the regimen was ...

A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.

Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have ...

Engineered chip mimics bone marrow and immune system, offering a faster, tailored path for cancer immunotherapy.

New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Scientists at UC Davis discovered a small genetic difference that could explain why humans are more prone to certain cancers ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...

Researchers led by John T. Wilson, Vanderbilt University associate professor of chemical and biomolecular engineering and ...